Edesa Biotech, Inc. Gains 41.94%

Edesa Biotech, Inc. (EDSA:NASDAQ) rocketted at $2.2, a gain of 41.9%. On Fri, Feb 27, 2026, EDSA:NASDAQ hit a New 2-Week High of $2.2. The stock appeared on our News Catalysts scanner on Tue, Feb 24, 2026 at 11:27 AM in the 'BIOTECH' category. From Fri, Feb 13, 2026, the stock recorded 55.56% Up Days and 50.00% Green Days

About Edesa Biotech, Inc. (EDSA:NASDAQ)

Stellar Biotechnologies Inc is a biotechnology company. The company is engaged in the aquaculture, research, and development, manufacture, and commercialization of Keyhole Limpet Hemocyanin (KLH). KLH is an immune-stimulating protein with an extensive history of safe and effective use in immunological applications. KLH can be used as an active pharmaceutical ingredient (API) and combined with a disease-targeting agent to create immunotherapies for the treatment of a variety of diseases. It derives its revenues mostly from Europe. Stellar primarily market and distribute products directly to biotechnology and pharmaceutical companies, academic institutions, clinical research organizations, and research centers.